TD Waterhouse Canada’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81K | Hold |
1,070
| – | – | ﹤0.01% | 1640 |
|
|
2025
Q1 | $3.96K | Hold |
1,070
| – | – | ﹤0.01% | 1582 |
|
|
2024
Q4 | $5.8K | Hold |
1,070
| – | – | ﹤0.01% | 1524 |
|
|
2024
Q3 | $4.45K | Hold |
1,070
| – | – | ﹤0.01% | 1520 |
|
|
2024
Q2 | $3.12K | Hold |
1,070
| – | – | ﹤0.01% | 1586 |
|
|
2024
Q1 | $3.88K | Hold |
1,070
| – | – | ﹤0.01% | 1579 |
|
|
2023
Q4 | $4.05K | Sell |
1,070
-500
| -32% | -$1.89K | ﹤0.01% | 1408 |
|
|
2023
Q3 | $4.81K | Hold |
1,570
| – | – | ﹤0.01% | 1370 |
|
|
2023
Q2 | $8.11K | Hold |
1,570
| – | – | ﹤0.01% | 1289 |
|
|
2023
Q1 | $3.1K | Hold |
1,570
| – | – | ﹤0.01% | 1456 |
|
|
2022
Q4 | $2.91K | Hold |
1,570
| – | – | ﹤0.01% | 1438 |
|
|
2022
Q3 | $2.41K | Hold |
1,570
| – | – | ﹤0.01% | 1480 |
|
|
2022
Q2 | $3.89K | Hold |
1,570
| – | – | ﹤0.01% | 1436 |
|
|
2022
Q1 | $4.68K | Sell |
1,570
-270
| -15% | -$804 | ﹤0.01% | 1460 |
|
|
2021
Q4 | $8.33K | Buy |
+1,840
| New | +$8.33K | ﹤0.01% | 1375 |
|